BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36279690)

  • 1. Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
    Gold D; Nicolay L; Avian A; Greimel E; Balic M; Pristauz-Telsnigg G; Tamussino K; Trutnovsky G
    Maturitas; 2023 Jan; 167():1-7. PubMed ID: 36279690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Melisko ME; Goldman ME; Hwang J; De Luca A; Fang S; Esserman LJ; Chien AJ; Park JW; Rugo HS
    JAMA Oncol; 2017 Mar; 3(3):313-319. PubMed ID: 27832260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer.
    Keshavarzi Z; Janghorban R; Alipour S; Tahmasebi S; Jokar A
    Support Care Cancer; 2019 Apr; 27(4):1325-1334. PubMed ID: 30729333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.
    Mension E; Alonso I; Anglès-Acedo S; Ros C; Otero J; Villarino Á; Farré R; Saco A; Vega N; Castrejón N; Ordi J; Rakislova N; Tortajada M; Matas I; Gómez S; Ribera L; Castelo-Branco C
    JAMA Netw Open; 2023 Feb; 6(2):e2255697. PubMed ID: 36763359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial.
    Costantino D; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2008; 12(6):411-6. PubMed ID: 19146203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the effect of vitamin D vaginal suppository on sexual function among postmenopausal women: study protocol for a randomized controlled trial.
    Sarebani Z; Alimoradi Z; Aali E; Mirzadeh M; Chegini V; Abbaspour M; Griffiths MD
    BMC Womens Health; 2020 Feb; 20(1):27. PubMed ID: 32070323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of non-ablative CO
    Lami A; Alvisi S; Baldassarre M; Zanella S; Amati V; Seracchioli R; Meriggiola MC
    Arch Gynecol Obstet; 2024 Apr; 309(4):1575-1583. PubMed ID: 38253692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
    Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; BSc AB; Martel C; Vaillancourt M; Balser J; Moyneur É;
    Menopause; 2018 Nov; 25(11):1339-1353. PubMed ID: 30358731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal CO
    Pearson A; Booker A; Tio M; Marx G
    Breast Cancer Res Treat; 2019 Nov; 178(1):135-140. PubMed ID: 31377895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.
    Le Donne M; Caruso C; Mancuso A; Costa G; Iemmo R; Pizzimenti G; Cavallari V
    Arch Gynecol Obstet; 2011 Jun; 283(6):1319-23. PubMed ID: 20577750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of CO
    Angioli R; Stefano S; Filippini M; Pieralli A; Montera R; Plotti F; Gatti A; Bartolone M; Luvero D
    Int J Gynecol Cancer; 2020 May; 30(5):590-595. PubMed ID: 32221022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microablative Fractional CO
    Salvatore S; Nappi RE; Casiraghi A; Ruffolo AF; Degliuomini R; Parma M; Leone Roberti Maggiore U; Athanasiou S; Candiani M
    Clin Breast Cancer; 2021 Oct; 21(5):e539-e546. PubMed ID: 33745867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review.
    Dos Santos CCM; Uggioni MLR; Colonetti T; Colonetti L; Grande AJ; Da Rosa MI
    J Sex Med; 2021 Jan; 18(1):156-166. PubMed ID: 33293236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up.
    Veron L; Wehrer D; Annerose-Zéphir G; Suciu V; Delaloge S; Pistilli B; Chaltiel D; Pautier P
    Breast Cancer Res Treat; 2021 Jul; 188(2):501-509. PubMed ID: 33891298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors.
    Carter J; Baser RE; Goldfrank DJ; Seidel B; Milli L; Stabile C; Canty J; Saban S; Goldfarb S; Dickler MN; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
    Support Care Cancer; 2021 Jan; 29(1):311-322. PubMed ID: 32358778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
    Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial.
    Hersant B; Werkoff G; Sawan D; Sidahmed-Mezi M; Bosc R; La Padula S; Kalsoum S; Ouidir N; Meningaud JP; Belkacemi Y
    Ann Chir Plast Esthet; 2020 Jul; 65(4):e23-e31. PubMed ID: 32513482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugate treatment with high concentration normobaric oxygen and hyaluronic acid for vaginal atrophy: a prospective study.
    Barbero M; Villasco A; Villa M; Badellino E; Marello E; Botta G
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2011-2017. PubMed ID: 36930500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.